The company is forecasting yet another bumper year.
Forecast second half ebit will be higher than last year, jeweller says.
Departing CEO Marko Bogoievski has led a remarkable period of achievement for MCo.
Follows $80,000 penalty from NZX Disciplinary Tribunal in October.
Covid has led to more online sales and consequently lower margins, company says.
Medicinal cannabis co inks $900,000 distributor deal.
Sales down on same period last year but a record total in 2021.
Company expects US FDA decision on Maxigesic tablets and IV over next six months.
Inflation and reopenings in the spotlight as post-GFC bull run slows.
But manager estimates full-year fees from CDC will be around half last year's level.
